Gemifloxacin

327 interactions 396 cited references

Also sold as: Factive Factive®

About Gemifloxacin

Gemifloxacin is used to treat pneumonia. Gemifloxacin may also be used to treat bronchitis but should not be used for this condition if there are other treatment options. Gemifloxacin is in a class of antibiotics called fluoroquinolones. It works by killing bacteria that cause infections. Antibiotics such as gemifloxac… Read the full Gemifloxacin drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Pimozide Piperaquine Sparfloxacin Mesoridazine Levoketoconazole Saquinavir

12 Contraindicated 294 Major 21 Moderate

All (327) Contraindicated (12) Major (294) Moderate (21)

Contraindicated

Gemifloxacin Bepridil An increased risk of QT interval prolongation Details Gemifloxacin Cisapride Propulsid® Increased risk of QT interval prolongation Details Gemifloxacin Dronedarone Multaq Increased risk of QT interval prolongation Details Gemifloxacin Levoketoconazole Recorlev An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Gemifloxacin Mesoridazine An increased risk of QT interval prolongation Details Gemifloxacin Pimozide An increased risk of QT interval prolongation Details Gemifloxacin Piperaquine An increased risk of QT interval prolongation Details Gemifloxacin Saquinavir An increased risk of QT interval prolongation Details Gemifloxacin Sparfloxacin An increased risk of QT interval prolongation Details Gemifloxacin Terfenadine An increased risk of QT interval prolongation Details Gemifloxacin Thioridazine An increased risk of QT interval prolongation Details Gemifloxacin Ziprasidone Geodon An increased risk of QT interval prolongation Details

Major

Gemifloxacin Amitriptyline Elavil An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gemifloxacin Sertraline An increased risk of QT interval prolongation Details Gemifloxacin Buprenorphine Belbuca An increased risk of QT interval prolongation Details Gemifloxacin Relugolix Orgovyx Increased risk of QT interval prolongation Details Gemifloxacin Acarbose Prandase® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gemifloxacin Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Gemifloxacin Arsenic Trioxide Trisenox An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gemifloxacin Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Gemifloxacin Arsenic Trioxide Injection Trisenox An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gemifloxacin Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Gemifloxacin Azithromycin AzaSite An increased risk of QT interval prolongation Details Gemifloxacin Alfuzosin UroXatral An increased risk of QT interval prolongation Details Gemifloxacin Alogliptin Nesina Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gemifloxacin Anagrelide Agrylin Increased anagrelide exposure and increased risk of QT interval prolongation Details Gemifloxacin Bedaquiline Sirturo Increased risk of QT interval prolongation Details Gemifloxacin Budesonide Entocort An increased risk of tendon rupture Details Gemifloxacin Budesonide Nasal Spray Rhinocort An increased risk of tendon rupture Details Gemifloxacin Budesonide Oral Inhalation Pulmicort An increased risk of tendon rupture Details Gemifloxacin Canagliflozin Invokana Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gemifloxacin Chloroquine Aralen® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gemifloxacin Dapagliflozin Farxiga Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gemifloxacin Dasatinib Phyrago An increased risk of QT interval prolongation Details Gemifloxacin Deflazacort Emflaza An increased risk of tendon rupture Details Gemifloxacin Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Gemifloxacin Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Gemifloxacin Dexamethasone Injection Decadron An increased risk of tendon rupture Details Gemifloxacin Dexamethasone Ophthalmic Dexacidin® (as a combination product containing Dexamethasone, Neomycin, Polymyxin B) An increased risk of tendon rupture Details Gemifloxacin Disopyramide Norpace An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.